Kzl-160 High Speed Granulating Machine for Pharmaceuticals

Name: Kzl-160 High Speed Granulating Machine for Pharmaceuticals
Brand: Shanghai Pharmaceutical Machinery Co., Ltd.
SKU: 772175635

Shanghai, ChinaShanghai Pharmaceutical Machinery Co., Ltd.

US$1.00-4,000.00

1 Set

Product profile

Certification

CE, GMP, ISO

Length (mm)

185

Diameter of Filter Hole (mm)

1~8

Model NO.

Kzl-160

Product Capacity (Kg/H)

150-300

Motor Power (Kw)

1.5

Revolving Speed (R/Min)

1000-1500

Finished Dosage Form

Granules

Precision

High Precision

Computerized

Non-Computerized

Customized

Non-Customized

Condition

New

Warranty

1 Year

Type

Granulator

Voltage

According to Your Requirement

Transport Package

Seaworthy

Specification

GMP

Trademark

SPM

Origin

Shanghai

HS Code

8479820090

Production Capacity

150~300kg/H

Company profile

Experienced TeamExhibition ExperienceImporters and ExportersLow MOQ

Shanghai Pharmaceutical Machinery Co., Ltd.

Shanghai, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 20 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤6.51h CertifiedTerms of Payment: T/T, LC, PayPal, etc.

AI-Powered supplier vetting

SummaryThe supplier is identified as a Shanghai-based combined trading company with listed pharmaceutical equipment products and machining-related facilities. It reports extensive customization, R&D activity with new products in the past year, export experience of 20 years, and exports representing 90% of total sales. After-sales support includes repair services and overseas agents or branches, but no overseas warehouse or showroom. Finished-product inspection instructions are reportedly available and uniformly followed. The supplier does not provide ODM services, lacks an available SDK, and does not provide OEM services for well-known brands. Evidence is insufficient to verify certifications, detailed financial credibility, production scale, or named customer cases.

After-Sales capabilityThe supplier reports repair as an overseas service offering and states that it can provide services through overseas agents or branches. However, it has no overseas warehouse or showroom, so the evidence supports some service access but not comprehensive overseas infrastructure.

R&D capabilityThe supplier reports R&D capability and states that it launched new products during the past year. It does not have an available SDK and does not provide ODM services, but these limitations do not negate the explicit evidence of recent product development.

Production capacityThe supplier lists machining centers, CNC and milling equipment, provides a broad pharmaceutical-equipment product range, and reports a finished-product inspection method with instructions that are uniformly followed. However, the supplied data does not quantify production capacity, output, or manufacturing ownership, so production strength is only partially evidenced.

Customization capabilityBoth R&D and design-service records explicitly list customization from samples, designs, full customization, minor customization, and flexible customization. This is direct evidence of a broad customization offering.